 SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 GLOBE NEWSWIRE -- Recro Pharma, Inc. Recro; NASD: REPH, a contract development and manufacturing organization CDMO dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that its chief executive officer, David Enloe, will deliver a corporate presentation as part of the H.C. Wainwright BioConnect 2022 Conference. The conference, which will take place January 10-13, 2022, is being conducted with a virtual format. 